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A PILOT STUDY OF THE IMPACT OF A PULMONARY CLINICAL DECISION UNIT ON 
OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
Introduction 
In today’s competitive environment, healthcare leaders are driven to reduce waste, 
remove inefficiency, and eliminate unnecessary hospital readmissions in ordered to achieve goals 
outlined in Section 3025 of the Affordable Care Act. Hospitalization accounts for nearly one-
third of the total $2 trillion spent on healthcare in the United States (Locker, 2011). While some 
readmissions are appropriate and unavoidable, a fragmented healthcare system and lack of care 
coordination causes patients to be admitted back into the hospital. Rehospitalizations are 
expensive, potentially harmful, and a sign of suboptimal care delivery.  
Attention to this issue has intensified with a new Hospital Readmission Reduction 
Program (HRRP), which penalizes hospitals for having high readmissions rates (Robert Wood 
Johnson Foundation, 2013).  Rates of patients readmitted within 30 day of discharge from the 
hospital impact the HRRP defined by the Center for Medicare and Medical Services (CMS).  The 
HRRP is CMS’s most noteworthy regulatory program, with potential reductions in future 
reimbursement according to performance relative to a baseline period.  In 2013, penalties were 
imposed up to 1%, with rates increasing per program mandates up to 3% in 2015. Performance at 
or above national levels enables acute care facilities to retain the 3% at risk amount, while below 
standard rates translate into decreased reimbursement (The CMS Blog, 2013).  
Background and Significance 
More than 2,000 hospitals across the United States were penalized by the government in 
October 2013, because their patients were re-admitted back to the hospital within 30-day of 
discharge.  Together these hospitals will forfeit about $280 million in Medicare funding over the 
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next 5 years.  This represents a major paradigm shift in healthcare payment structure, in which a 
new reimbursement structure is reliant on patient outcomes (Rau, 2012).  The fee-for-service 
system, as well as some capitation methods, offer few incentives for preventing readmissions 
that result from poor outpatient care or complications related to an initial hospitalization. One in 
twelve adults discharged from the hospital are readmitted within 30 days. The cycle of 
readmissions added $16 billion to the cost of healthcare in the United States. Due to the 
astronomical cost, the HRRP is a method designed to ensure hospitals are accountable to making 
certain that systems and structures are in place to reduce unplanned readmissions. (Reid, 2012).   
According to Jencks, Williams and colleagues (2009), 19.6% of the 11,855,702 Medicare 
beneficiaries were rehospitalized within 30 days and 34% were rehospitalized within 90 days; 
67.1% of patients who had been discharged with medical conditions and 51.5% of those who 
had been discharged after surgical procedures were rehospitalized or died within the first year 
after discharge (Jencks, Williams, & Coleman, 2009).  Among patients who were re-
hospitalized within 30 days after a surgical discharge, 70.5% were rehospitalized for a medical 
condition.  About 10% of rehospitalizations were likely to have been planned.  The average 
length of stay of rehospitalized patients was 0.6 days longer than that of patients in the same 
diagnosis-related group (DRG) whose most recent hospitalization had been at least 6 months 
previously (Jencks et al., 2009).  The study provided supporting evidence that rehospitalization 
among Medicare beneficiaries is widespread and costly. 
Re-admissions are measured by a ratio, dividing a hospital’s number of “predicted” 
30-day re-admission diagnoses by the number that would be expected. Ratio is a comparison 
of the average re-admission rates with other hospitals with similar patients.  The HRRP 
policies currently apply to patients who meet the operational definition for 30-day re-
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admission for diagnoses of Acute Myocardial Infarction (AMI), Heart Failure (HF) and 
Pneumonia (PN) ("Re-admission Reduction Program," 2013). However, in Fiscal year 2015, 
the HRRP expanded the list of patient types to include Chronic Obstructive Pulmonary 
Disease (COPD), Coronary Artery Bypass Grafts (CABG), Percutaneous Transluminal 
Coronary Angioplasty (PTCA), Stroke, other vascular surgical procedures (The CMS 
Blog, 2013). 
         Over 5% of all deaths and one in eight admissions from the emergency department are 
patients with COPD.  In the state of Kentucky, more than 9% of the population has a diagnosis 
of COPD according to the 2013 Behavioral Risk Factor Surveillance System Survey (Center for 
Disease Control and Prevention, 2012).  According to the data specific to COPD 30-day hospital 
readmission rates for Norton Audubon Hospital, the baseline in 2013 was 18.4%. 
It is predicted that COPD will move from the 12
th
 leading cause of disability to the 5
th
 
place by the year 2020 (Sridhar, Dawson, Roberts & Partridge, 2008). COPD is one of the most 
common medical conditions associated with re-admissions. Two targeted strategies being used to 
improve readmission rates of patient with COPD are the development of Observation Units and 
admission of patients classified as observation status. Observation Units, also known as Clinical 
Decision Units (CDU) and or Short Stay Units (SSU), are designed for patients whose clinical 
conditions are unclear and for whom additional evaluation is needed in order to make a clinical 
decision to admit the patient to inpatient. The names used to identify observation location are 
interchangeable: CDU, OU, and SSU. These locations where patients are managed, utilize the 
same principal for providing care to patient between 8 – 24 hours. Services provided to patients 
in observation areas are typically protocol driven interventions to determine appropriate 
monitoring, diagnostic testing, assessment of clinical symptoms, laboratory testing, and response 
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to treatment in order to determine whether a patient requires additional treatment or if the patient 
is to be admitted as an inpatient.  
Furthermore, the quality of life for patients with COPD is often compromised due to the 
course of the disease.  COPD impairs the quality of life, by preventing people with this condition 
from socializing and enjoying life and hobbies they love. Patients with COPD experience limited 
energy levels and may feel frustrated and angry about an inability to do what they want to do in 
life (Zamzam, Azab, Wahsh, Ragab & Allam, 2012). Anxiety and depression are frequently 
associated with diseases which further contribute to rehospitalization. When patients with COPD 
are admitted to the hospital, condition treatment and medication adjustment are the primary goals 
of getting the patient well enough for discharge. Unfortunately healthcare many opportunities for 
addressing underlying issues that contribute to unplanned readmissions. Hospitalized patients and 
/or their families often receive limited education about self-care and the prevention of unplanned 
readmissions.  There is no formal hand-off to post-acute care providers, nor are socioeconomic 
factors impacting the disease discussed with the patient.  When subsequent exacerbation arises, 
the emergency room is the typical solution (Graf et al., 2012). 
Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) represents a 
major burden to the healthcare system. A study by Reid (2012) reported that the cost of 
readmission increased to $97 billion annually when including patients readmitted within one 
year.  Patients with COPD are frequently readmitted due to the growing numbers of co-
morbidities and mortalities associated with the disease.  These patients utilize an enormous 
amount of healthcare resources.   
Diez and colleagues (2008) evaluated social determinates and predictors of the cost of care 
associated with COPD patients in primary care and acute care settings.  The authors identified 
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that the largest component of cost associated with the treatment and management of COPD 
occurred during hospitalization.  On average, the total cost per COPD patient admitted to an 
acute care facility was $1,922.72 + $2,306.44.  The cost varied according to the admission status.  
Patients, assigned to an observation status, spend less time in the hospital than patients assigned 
to an inpatient status.  Patient status ensures the avoidance or abuse of the hospital system by not 
admitting patients who are not "sick" enough to require an inpatient stay.  Observation status is 
defined by CMS as the utilization of a bed for periodic patient monitoring to evaluate the 
patient’s condition in order to determine the need for an inpatient admission (Diez et al., 2008).  
Hospitals are capitalizing on this distinction through the introduction of observation units 
(OUS).  When patients are classified as status observation, and /or are admitted to an OU, the 
billing is different than an inpatient admission.  Observation status is reimbursed according to 
the Outpatient Prospective Payment System.  Observation is an alternative to inpatient 
admissions since it enables the provider the opportunity to determine if an admission is 
necessary (Schmidt & Schmidt, 2014). When patients are discharged from an observation area, 
the time spent in observation status does not count as an inpatient admission; thereby, OUs and 
observation status affect hospital readmission rates. OUs enable the provider to determine if the 
patients’ condition warrants medical necessity for an inpatient and has been frequently used 
with cardiac patients.  However, the effectiveness of this approach with COPD has not been 
thoroughly evaluated.  
Purpose Statement  
The purpose of this retrospective study was to analyze the impact of a pulmonary clinical 
decision unit (PCDU) on patient outcomes related to COPD.  At Norton Audubon Hospital 
(NAH), patients with COPD who were not ready for discharge from the emergency department 
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(ED) and who did not meet inpatient criteria were admitted to the hospital as observation status 
to a PCDU during the time period from January 28, 2014 - August 31, 2014. The PCDU staff 
provided expedited evaluation and utilized protocols to provide therapeutic interventions and 
coordinated services in order to discharge patients home or to determine the need for an 
inpatient admission. The study will measure the impact of cohorting patients with COPD in a 
PCDU on the cost of care, 30-day hospital readmission rates, and subsequent emergency 
department visits within 7 days of discharge 
  Literature Review 
An integrative review was performed on evidence-based literature relating to use of 
OUs.  The following databases were searched from the years 2004 to present: CINAHL, 
PubMED, Medline and Cochrane database Systemic Reviews.  Key words used in the 
database were: Patient Protection Affordable Care Act, hospital re-hospitalization, 
preventable COPD re-admissions, and COPD cost of care, clinical decision unit, short stay 
unit and observation units.  The search was limited to human adults over 18 years from 2004 
to 2014.  Inclusion criteria included a focus on high risk readmissions, clinical decision units, 
CMS criteria for admission as compared to observation status, ED visits for COPD, and COPD 
readmission strategies.  Out of 150 citations reviewed, 15 studies met the inclusion criteria. 
The use of Observation Units (OUs), is gaining popularity as a strategy for decreasing 
emergency department crowding, reducing hospital admissions and lowering costs. According 
to Suri (2011), observation units (OUs) first became popular after the paradigm shift from fee- 
for-service to value-based purchasing. The purpose of the OU within the structure of an 
Accountable Care Organization (ACO), to increase healthcare systems’ accountability by 
developing and implementing strategies to improve patient outcomes while also lowering 
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healthcare costs.  ACOs achieve cost savings by reducing avoidable admissions, preventing 
unplanned readmissions, and decreasing ED visits. Delivering healthcare services while 
offering hospitals financial incentives are the governing principles associated with an ACO 
model. Challenges confronted by hospitals in terms of controlling cost, decreasing crowded 
emergency departments , and improving outcomes for patients support the business case for 
implementing observation units or CDUs. (Suri, 2011). 
Decker and colleagues (2008) performed a prospective, randomized trial of an emergency 
department observation unit (EDOU) for acute onset of atrial fibrillation.  The purpose of the 
study was to investigate an EDOU protocol for managing acute onset of atrial fibrillation and to 
compare the treatment of EDOU patients to those under usual hospital admission management. 
The study was done over 3 years (September 1999- December 2002) in the EDOU of a tertiary 
referral center.  The EDOU utilized protocols to manage patients admitted to the area. At the end 
of the 39 month study period, 85% of EDOU patients were converted to Sinus rhythm versus 
73% in the routine care group (difference 12%; CI -1% to 25%; P < .06).  The mean LOS was 
10.1 versus 25.2 hours, (difference 15.1 hours; 95% CI 11.2 to 19.6; P <.001) for EDOU and in 
hospital respectively. Nine EDOU patients required inpatient admission. Eleven percent of 
EDOU group had recurrence of Atrial fibrillation during follow-up versus 10% of the routine 
inpatient care group (difference 1%; 95% CI -9% to 11%; P < .93) (Decker, et al 2008,).  In 
summary, the EDOU integrated protocols to control heart rate and cardiovert patients when 
necessary. The length of stay in the EDOU was significantly better in these patients when 
compared to those under routine care. 
The majority of CDU research has been conducted on patients with HF. Because the 
population is living longer, HF is mostly observed in the elderly population. Due to the 
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prevalence of HF, more studies have been conducted with this population. The diagnosis of HF 
is the most expensive diagnosis for Medicare healthcare systems exceeding $34.8 billion in 2005 
(Linden & Milstein, 2008.).  Unfortunately, frequently reoccurring symptoms of HF result in 
multiple ED visits which are followed by multiple readmissions. Heart Failure is a disease that is 
characterized by frequent visits to the ED due to the steady deterioration of the patients’ clinical 
presentation and patterns. As the disease progresses, the quality of life is negatively affected over 
time. 
Peacock and colleagues (2006) reviewed innovative options for managing 
decompensated heart failure in an EDOU.  EDOU protocol driven patient management was 
integral to the success of the unit.  In a pre and post study of 154 decompensated HF EDOU 
patients, the investigators demonstrated that protocol-driven EDOU treatment of decompensated 
HF is an effective and safe method to manage patients and to decrease inpatient admissions. The 
ED revisit rate decreased by 56% (0.90- 0.51; P < 0.000) during the 90-day follow-up period. 
Another statistically significant outcome from the study demonstrated a reduction in 90-day 
inpatient readmission rate of 64% (0.77 – 0.50; P < 0.007).  Finally, 90-day mortality and ED 
readmission decreased from 4% to 1% (P= .096). A structured outpatient EDOU management 
protocol positively decreases 90-day rates of emergency department revisit rate and decreases 
inpatient hospitalizations (Peacock, 2005). 
Another study examined optimizing patient care in an OU to decrease HF readmission 
rates (Peacock, 2005). Patients received specialized treatment plans in the cardiac OU for acute 
decompensated HF. The OU provided an alternative strategy to lowering hospital readmissions 
rates. Entry to the OU was determined by a set of criteria and treatment protocols once the 
patient was admitted to the OU. To determine appropriate patient placement to an observation 
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unit for heart failure, the following information was collected while the patients were in the 
emergency department: the medical history and physical, chest x-ray, measurement of B-type 
natriuretic peptide (BNP), ECG and cardiac markers. According to the results, the investigators 
concluded that the implementation of an observation unit with patient specific protocols and 
standing orders for decompensated HF was associated with a 56% reduction in the 90-day HF 
emergency department  revisit rate (P <.0001) and a reduction in the 90-HF Rehospitalization 
rate (P=.007).  Additional benefits associated with the observation units were a reduction in     
90-day mortality rate from 4% to 1% (P < .096) (Peacock et al., 2006).    
Proactive evaluation and effective management of HF in an OU, prevents unforeseen 
complications associated with decompensated heart failure. Aggressive patient management, 
education and follow-up discharge planning supports the business case for implementing an OU 
as a component of patient care. Jagminas and colleague (2004) examined the optimal location for 
an OU. A retrospective study was conducted for the purpose of comparing the utilization of an 
EDOU, to an in hospital observation unit (IHOU) for chest pain in the same acute care facility. 
There were 440, or 36.9% of 1190 patients, with chest pain presenting to the ED over a 5 month 
period who were admitted to the EDOU, while the IHOU admitted, 973 or 69.3% of 1404 
patients from the ED.  There were fewer patients with chest pain who were converted to an 
inpatient status from the EDOU, 35 patients or 7.9% of 440 (P < 0.000), when compared with 
the IHOU, n = 187(19.2%) or 973; (P <.001). The average cost of care for each EDOU patient 
was $889.87 (95% CI 862.8 – 916.9) as compared to $1,039.70 (95% CI 991.7 – 1087.7) for 
each IHOU patients (Jagminas & Partridge, 2005). According to the findings, the cost of care 
was higher when patients were in the IHOU as compared with the EDOU for managing low-risk 
to moderate risk patients with chest pain. In summary, observation units have proven to reduce 
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inpatient admissions, decrease emergency room crowding and control cost (Suri, 2011). 
Furthermore, the cost of care for managing low-risk patients with disease specific protocols in an 
OU is an efficient method for managing patients (Jagminas & Partridge, 2004).  
When considering a location for an observation unit and the strength of evidence for 
managing patients in an EDOU, the majority of studies were conducted on patients with 
decompensated HF. A structured protocol- driven EDOU for the treatment of decompensated HF 
has been proven to be an effective and safe method to managing patients and decreasing 
inpatient admissions (Peacock, 2005). There is a growing body of evidence in support of 
observation units for managing patients with HF. Observation units that implemented decision 
trees according to 3 process maps to differentiate patients at low, intermediate and high risk of in 
hospital mortality, provided guidance for providers and structure to ensure that the patient’s 
condition meets the criteria for admission to an observation unit (Peacock et al. 2006).  
The goal of observation status and the utilization of OUs to decrease cost by creating 
incentives for efficient, effective healthcare. Healthcare is making positive gains to limit cost by 
proactively preventing complications and avoidable days in the hospital.  Studies support 
observation medicine by cohorting specific patient types to an observation unit or clinical 
decision unit.  Due to the growing number of patients diagnosed with COPD, cohorting patients 
and using protocol driven order sets, enables physicians to spend more time to stabilize the 
patient and to determine medical necessity (Decramer & Wim, 2013).  The protocol driven care 
for COPD is based on the Gold recommendations (Vestbo, et al. 2013). Regardless of where 
OUs are within the hospital environment, the evidence supports deploying and executing 
resources to ensure these specialty areas are equipped and staffed with qualified healthcare 
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workers. OUs contribute to improved care, and to control the cost of healthcare for vulnerable 
patient population. 
Methods 
Development of Interventions 
An innovative approach to preventing unplanned admissions, reduce cost, and reduce 
ED visits between admissions is to apply a data-driven, quality strategy to improve patient 
outcomes.  The design and implementation of the PCDU at NAH followed the DMAIC model 
(Define, Measure, Analyze, Improve and Control). DMAIC is a subcomponent of Six Sigma 
Performance Improvement Methodology.  The fundamental objective of Six Sigma 
methodology is to implement evidence-based strategies by means of focusing on process 
improvement and eliminating variations (Six Sigma, 2009).  
The Six Sigma DMAIC is performance improvement methodology consisting of five 
phases. During the Define phase, the executive leadership team at Norton Audubon Hospital 
(NAH) identified that COPD 30-day hospital readmission rates were higher than the national 
average. The United States average 30-day hospital readmission rate for Medicare patients with 
a diagnosis of COPD is 18.0 % (Agency for Healthcare Research and Quality, 2013).  NAH 
readmission baseline rate for COPD was 18.4% in 2013.  The length of stay for patients with 
COPD is 4.52 days and cost of care is $2,966 per patient. These factors associated with 
managing COPD led to the development of a committee to address these issues.   
In the define phase, the champion for the project contacted the lead investigator and 
requested assistance in leading a committee to address COPD outcomes. The lead investigator 
and the project sponsor, created a multidisciplinary team to develop processes and to 
implement evidence based strategies to improve outcomes for patients with COPD.  To make 
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certain that the committee members accurately represented the healthcare team, an in-depth 
analysis was completed to determine which internal and external stakeholders affect the 
process. The stakeholders were identified as representatives from nursing, information 
services, pulmonologists, pastoral care, respiratory care and care management. The team 
created a charter, which defined the scope of the project, as well as identified how the problem 
affects the patient and the organization (see Appendix A).  Due to the shift in hospital 
payment and more focus on value, the committee validated that patients with a diagnosis of 
COPD are at the greatest risk for readmissions due to the number of co-morbidities associated 
with the disease.   The scope of this project was specific to patients admitted and discharged 
with a primary diagnosis of COPD. 
The Measure phase involved gathering information on the physical characteristics 
accompanying COPD and the current situation in order to provide an understanding of the 
improvement efforts.  This phase was crucial in understanding current performance and 
processes impacting readmissions and the cost of care.  The data were abstracted from the 
electronic medical records to determine the demographics related to patients with COPD; age, 
discharge disposition and gender (see Appendix B). Additional data, measuring the cost of care, 
length of stay, Emergency Department visits within 7 days and 30 day readmission rates were 
used to determine the financial impact of COPD (see Appendix C). 
 During the Analyze phase, the team identified root causes of variations and gaps in care 
affecting clinical outcomes associated with COPD.  Variations identified by the team consisted 
of inconsistent utilization of outdated protocols, lack of a mechanism for identifying patients at 
risk for readmissions, inconsistent education provided to staff regarding pulmonary disease 
management, absence of or no pulmonary physician consulted on the case, patients admitted to 
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different nursing units, and patients with no medical home or primary care physician. In the 
Improve phase, the team developed the future state map, goals and researched best practice for 
managing AECOPD.  According to the evidence, hospitals that admitted patient with 
AECOPD to an OU had a reduction in 30-day hospital readmission rates and cost of care 
(Decramer & Wim, 2013).   During this phase, the project sponsor collaborated with the chief 
finance officer, the chief nursing officers and Pulmonologists to develop a business plan which 
included timelines for opening a PCDU for patients who were assigned an observation status with 
pulmonary disease.  The clinical experts on the committee developed the protocols associated 
with the PCDU (see appendix D). The focus on multidimensional care which was patient-
centered, safe, cost-effective, efficient, evidence based and culturally competent was the 
foundation supporting the PCDU. The PCDU was located on 4 east nursing area. The unit was a 
23-hour observation unit specifically designed for patient with pulmonary diagnoses.  The PCDU 
had 8 observation beds which allowed patients to be assessed using evidence-based strategies 
with optimal resource utilization. Optimal care of patients with diagnoses of COPD was the goal 
of staff members who worked in the PCDU.   
The staff were provided with in-depth education which was specific for the management of 
COPD. The education materials were created using the COPD “Gold Standards” as the best 
practice for managing COPD (Vestbo, et al. 2013). COPD protocols were created by the clinical 
leadership team representing the PCDU.  Based on the evidence, the education provided to the 
staff covered the following areas; medication use, recognition and management of chronic 
obstructive pulmonary disease exacerbation symptoms, lab values, bronchial hygiene, oxygen 
modalities, breath sounds, smoking cessation, and advance directives. The care of the patient 
with COPD is very challenging and complex. The comprehensive education and training 
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provided to the staff was an essential component to providing an infrastructure within the PCDU 
to ensure that the staff working in  the PCDU were consciously and clinically competent.    The 
PCDU opened January 27, 2014.  Patients admitted to the observation unit were required to meet 
the following criteria:  
 High likelihood of correction to baseline status within 48 hours. 
 Acceptable vital signs: blood pressure. >100/60, respiratory rate < 28, pulse < 120. 
 Pulse oximetry 90% or higher on room air, correctible to > 90% on oxygen, on < 50% 
FiO2. 
 No sign or symptoms of fatigue or impending fatigue 
 Alert and without any medical status changes 
 Chest X-Ray without an apparent acute process. 
Once patients were admitted to the PCDU, the protocol order set was initiated.  If the patient 
did not have a pulmonologist, an automatic referral was sent to the pulmonary specialists. While 
in the PCDU, all patients with COPD were seen during multidisciplinary rounding. Patients are 
provided with the COPD education folder, which includes the booklet “Learning to Live with 
COPD”. The booklets were given to the patient upon initial diagnosis and available for reference 
upon subsequent admissions.  Patient education was progressive while in the PCDU.  
Information taught to the patient and/or family members consisted of, living in a smoke free 
environment,  medication compliance, maintaining comfortable breathing by using directives ( 
e.g. pursed-lip breathing technique, forward body positions), managing stress, preventing and 
treating COPD exacerbation, maintaining an active life style and healthy diet. While in the 
PCDU, the nursing staff discussed the benefits associated with pulmonary rehabilitation as an 
opportunity for successful long-term COPD management.  Once the patient was stable and in 
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agreement with the transitional plan for pulmonary rehabilitation, a referral was sent to the 
department.  The nursing staff in the PCDU were responsible for scheduling a follow-up 
appointment with the patients’ primary care physician prior to discharge.  These strategies 
ensured that those patients were able to manage their disease once discharged from the hospital.  
Another component to the Improve phase consisted of leveraging available technology to 
identify patients at risk for readmission. Predictive analytics were embedded into the PCDU 
clinical work flow. A predictive analytic tool was built into the electronic health record. Epic 
Readmission Manager (RAM) was a health intelligence platform which proactively identifies 
patients at risk for hospital readmissions.  The strategy for preventing unplanned readmissions  
by using Epic RAM, in conjunction with admitting patients with Acute Exacerbation Chronic 
Obstructive Pulmonary Disease (AECOPD) to the PCDU. Epic RAM forecasts the probability of 
a patient being readmitted.  The forecast was based on the number of prior emergency 
department visits within the past 6 months, the time since the last discharge, the name of the 
primary care physician, age, living arrangements, and the ability to perform activities of daily 
living, residence type and reliable transportation.  These markers are included in Epic RAM 
readmission predictive index (PI).  This score was used to risk stratify patients and to identify 
patients who require advanced discharge planning or additional care transitional services to 
prevent an unplanned readmission.  The Care Manager assigned to the PCDU would track and 
monitor PI scores of 6 or greater. A PI score of 6 or greater is an alert to the care manager to 
further evaluate the patient by using the Risk Readmission Assessment tool in Epic (see 
appendix E). 
The final phase is Control.  Control involves making certain the improvement strategies were 
hardwired into the culture (Six Sigma, 2009). The Control phase involves creating a process 
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control plan and to sustain the improvements. Developing and implementing evidence-based 
strategies for improving outcomes for patients with a diagnoses of COPD is a priority within 
Norton Healthcare (NHC).  The evidence supports hospital environments that embraced OUs as a 
means of managing patients with chronic disease.  
Evaluation Plan 
Sample criteria were analyzed and evaluation has been completed for patients treated 
during the time period from January 28 – August 31, 2014 with the following diagnostic 
related groups (DRGs) and International Statistical Classification of Disease ICD codes (ICD-
9 codes) for COPD: 190, Chronic Pulmonary COPD WMCC, 191, Chronic Obstructive 
Pulmonary Disease, W CCMS and 192, Chronic Obstructive Pulmonary Disease 
W/OCC/MCC MS (Schmidt & Schmidt, 2014). Additional data analysis were completed with 
patients who were admits to the PCDU as observations according to ICD-9 codes (See 
appendix F for CMS reimbursement rates for COPD).  These codes are based on disease types 
and are utilized by healthcare settings in the United States and many other parts of the world 
(Mitus, 2008). ICD 9 codes are a common language that is used for understanding outpatient 
diagnoses the same way.  ICD 9 codes for COPD observation are as follow 491.21, Chronic 
obstructive asthma with status asthmatic, 491.22, Chronic Obstructive Asthma, with Acute 
exacerbation, 491.9, Unspecific Chronic Bronchitis and 492.8, other emphysema. ICD-9 codes 
are assigned to patients who are admitted as observation.   
Design 
The study was a pilot of a retrospective study of data on patients admitted with COPD 
exacerbations to two different hospital settings within NHC. Norton Audubon Hospital 
(NAH) is a 432-bed acute care hospital specializing in cardiac, cancer, surgical, pulmonary, 
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neurology, and orthopedic, vascular, emergency and diagnostic care.  The treatment group 
involved patients admitted as observation NAH on 4 East and 4 West. Patients who are 
assigned to an observation status primary diagnosis are based International Classification of 
Disease, Ninth Revision. 
The other acute care facility included in the study is Norton Hospital (NH) a licensed 
642-bed hospital with particular emphasis on advanced diagnostic and surgical procedures.  
NH served as the comparison facility. The hospital is a teaching facility for the University  
of Louisville School of Medicine. Norton Hospital’s patients with COPD are the comparison 
group in the study.  According to availability of beds in Norton Hospital, patients with COPD 
are admitted to different medical-surgical units.   
Data Collection Plan 
The data collection plan consisted of the following data elements for patients admitted as 
observation for COPD:  the facility, admitting unit, discharge unit, discharge disposition, 
primary diagnosis, hospital status, co-morbidities, and length of stay in hours, age, and gender, 
charges per case, direct variable cost, observation hours and Pulmonologist on case.  The 
evaluation of the outcome indicators will measure hours in observation, COPD 30-day 
readmission rates ED, 7day ED readmissions, variable cost per case and charges (see the 
Appendix G). 
       The primary outcomes associated with the proposal are: Thirty day readmission rates, the 
cost of care and ED 7 day readmission. The operational definitions for the financial variable 
associated with the cost of care are: charges- a price for services render while in the hospital, and 
variable cost- includes the cost for medications and supplies (Modern Healthcare, 2012).  The 
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project timelines illustrates the road map for completing the requirements associated with the 
capstone project (see Appendix H). 
Required Approval 
The approval of the System Vice President of Medical Affairs and Care Continuum, The 
University of Louisville Institutional Review Board (IRB) office, and Norton Healthcare Office 
of Research Administration was received. The waiver was the required documentation for 
approval for evaluating the pilot project (see Appendix I). 
Ethical Consideration 
Permission to conduct the study was obtained according to policies outlined in the 
Institutional Review Board at Bellarmine University and Norton Healthcare. The analysis of 
existing data qualified this study for an exempt status.  The project was retrospective analysis 
based on data retrieved from the electronic medical record. Confidentiality was maintained by 
using the medical record number.  The data were password protected and kept on a personal 
computer in a locked office at NHC. 
Data Analysis  
Descriptive statistics were used to determine the characteristics of age, gender, discharge 
disposition, payer source, attending physician and secondary comorbidities. The Mann-Whitney 
U test was used to determine statistically significant difference in charges, variable cost and 
hours in observation between the control group and the intervention group. The Mann-Whitney 
U test is a nonparametric analysis that statistically verifies the likelihood that two independent 
groups have been taken from the same population. The Mann-Whitney U test is based on the 
comparison of each observation from the control group with each observation from the 
intervention group (Plichta & Garon, 2009). In other words, the Mann-Whitney test enables the 
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researcher to observe and compare difference between the performance of the control group and 
the intervention group. 
Results 
Pilot Characteristics  
The pilot consisted of twenty-seven patients. Eight patients were in the intervention 
group and nineteen patients were in the control group. In the study, females with COPD 
diagnosis were more likely to be admitted to an observation status. Medicare and Kentucky 
Exchange were the major payer source and the majority of attending physicians overseeing the 
care of these patients were internal medicine specialists. Internal medicine specialists at NAH 
and NH are hospitalists employed by NHC. All patients in the study were discharged from 
observation status to home.  Both groups had patients with secondary diagnoses including atrial 
fibrillation, acute or chronic renal failure, and diabetes accompanied by a primary diagnoses of 
COPD (Table 1).   
Table 1.  Characteristics difference between the control group and intervention group 
                                                                      Mean (SD) 
                                                      Control Group                        Intervention Group 
                                                               ( N = 19)                                  (N = 8) 
Age                                              62 (SD= 12.25)                      61 (SD = 13.57) 
Gender 
Male                                      8 (42%)                         4 (50%)   
Female                                                  11(58%)           4 (50 %) 
 
Payer 
Medicare                     7 (37.%)            4 (50%)     
Kentucky Exchange                     8 (42%)         3 (37.5%)   
Humana                                   1 (3.7%)         1 (12.5%)   
United Healthcare                    1 (3.7%)       
Private                      1 (3.7%) 
 
Discharge disposition    
Home                                                  19 (100%)                                8 (100%) 
 
Attending Physician 
Pulmonologists                                   1 (5.2%) 
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Internal Medicine                                  12(63%)          8 (100%)   
Family Medicine                                    4 (21%) 
Infectious Disease                    1 (5.2%) 




Atrial Fibrillation                                1 (12.5%)                               1 (12.5%) 
Tobacco Use Disorder                      2 (10.52%)                     
Iron Deficiency                                   1 (12.5%)                        
Diabetes                                              1 (5.26%)                               1 (12.5%) 
Hypertension                                          4 (21%)                            
History of Tobacco Use                                                                    1 (12.5%) 
Acute Respiratory                               1 (5.26%)                          
Failure 
Acute and Chronic                               1(5.26%)                               1(12.5%) 
Respiratory Failure                                                   
Shortness of Breath                              1(5.26%)                        
Long Term Use Meds                          1(5.26%) 
Coronary Artery Disease                                                                     2 (25%) 
Chest Pain                                         2 (10.52%) 
Chronic Asthma                                                                                1 (12.5%) 
Chronic Pulmonary Heart Disease   2 (10.52%) 
Convulsion Necrosis                                                                         1 (12.5%) 
Pneumonia Organism                          1(5.26%)  
Hypothyroidism                                  1 (5.26%)      
Observation Hours 
Hours in observation for the control group, ranged from 22 hours to 96 hours with a mean 
of 38.47(SD = 20.01). The intervention hours in observation ranged from 16 hours to 48 hours 
with a mean of 34.50 (SD =13.42) The mean rank represents observation hours per patient while 
in observation status with COPD. The control groups (Mdn = 14.05) did not differ significantly 
from the intervention group (Mdn = 13.88, U = 75, z = 0.0265, p = 0.38). Observation hours were 
about the same in both hospitals over the same period of time. (Table 2).  
Table 2. Observation hour for the control group and intervention group 
Mean(SD) 
                              Control Group                        Intervention Group 
                                  ( N = 19)                                  (N = 8)                       z          P 
Mean Rank                14.05                                       13.88                         0.027    0.38      ns* 
22 
 
Observation hours    38.47(SD = 20.01)                    34.50 (SD = 13.42)                 
*ns = not statistically significant 
Charge Results 
Financial analyses were performed to compare the cost associated with charges acquired 
while in observation. Charges were calculated utilizing the cost per day of caring for a patient in 
observation. Charges in the control group ranged from $7,012 to $24,853 a mean of $13,437 (SD 
=5,133) The intervention group charges ranged from $7,462 to $15,510 with a mean $10,265(SD 
= 2,982) The mean rank represent charges per patient while in observation status with COPD. 
The control groups (Mdn = 15.47.) did not differ significantly from the intervention group (Mdn 
= 10.5), U = 48 , z = 1.4602 , p = 0.1443.  Charges were calculated utilizing the cost per day of 
caring for a patient in observation.  (Table 3) 
Table 3. Charge results comparing the control group and intervention group 
Mean(SD) 
                              Control Group                        Intervention Group 
                                  ( N = 19)                                  (N = 8)                       z          P 
Mean Rank                15.47                                       10.5                         1.4602    0.1443      ns* 
Charges                     $13,437 (SD= 5,133)                   $10,265 (SD = 2,982)                 
*ns = not statistically significant 
Direct Variable Cost 
Direct variable cost  while in observation in the control group ranged from $627 to 
$3,444 with a mean of $1,306  (SD = 655)  The intervention group variable cost ranged from 
$216 to $1,125 with a mean $725 (SD =303 ) The mean rank represents charges per patient while 
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in observation status with COPD. The control groups (Mdn = 16.58) differ significantly from the 
intervention group (Mdn = 7.88 , U = 27 , z = 2.5753 , p = 0.00988. The PCDU provided a site to 
cohort patients with COPD which has demonstrated a significant reduction in direct variable 
cost. (Table 4) 
Table 4. Direct variable cost comparing the two groups 
Mean(SD) 
                              Control Group                        Intervention Group 
                                  ( N = 19)                                  (N = 8)                       z               P 
Mean Rank                16.58                                       7.88                           2.5753    0.00988      s* 
Direct variable cost  $1,306(SD = 655)                $725 (SD = 303) 
*s = statistical significant 
Readmission Outcomes 
Evaluation of readmission data relating to the control group and the intervention group 
was conducted to compare the difference between  7-day ED readmission and 30-day 
readmission percentages.  The data indicated that there are variations among the two groups 
when comparing readmission rates (Table 5). 
Table 5. Readmission Percentages 
                                                                  Percentage 
                                       Control Group                        Intervention Group 
                                           ( N = 19)                                  (N = 8)                        
7- day ED readmission            0                                        1 (12.5%)       
30-day readmission                 1 ( 5.2%)                            0 
 
Discussion and Conclusion 
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The primary objective of this quality improvement pilot was to determine if the PCDU 
reduced COPD 7-day and 30-day readmissions rates, lowered direct variable cost and decreased 
charges occurred while in the hospital. The capstone pilot was conducted on a small group of 
patients who were admitted to observation status with a diagnosis of COPD. Research in the 
development and use of observation units is still early in its adoption and implementation.  
Multiple studies have demonstrated the clinical effectiveness of care delivery in specialty 
observation units (Suri, 2011).  In the intervention group, patients were admitted in observation 
status to the 4
th
 floor at Norton Audubon Hospital. The patients in this group were managed 
using protocols and order sets that were evidence based using the GOLD Standard for COPD as 
cited in Decramer & Wim, 2013.   The control group consisted of patients admitted to Norton 
Hospital under observation status. The patients were not limited to any specific units, and there 
was no standardization in treatment. The findings are not surprising due to the length of the pilot 
and the sample size.  
Comparison of the outcomes of readmission between the two groups did not reveal any 
trends. There was one 7-day readmission in the intervention group and no readmission at 30 
days. The control group had no 7-day readmission and one readmission in 30 days. However, 
there was a statistically significant difference in direct cost, with a lower cost in the control 
group ($10,265 vs. $13,437; p=0.000988).  A longer period of evaluating the effectiveness of the 
PCDU would be ideal in order to determine the potential  long term impact of the unit.  
 Healthcare organizations are creating observation beds within ED’s or within a nursing 
unit. During the pilot, the location of the PCDU was on the fourth floor of Norton Audubon 
Hospital . The PCDU was created by converting 8 existing beds on a 36-bed medical surgical 
unit. The conversion of the observation beds decreased inpatient bed capacity on that unit to 28 
25 
 
inpatient beds.  Therefore, in the pilot, the analysis does not consider the startup cost associated 
with the PCDU.  
The average daily patient census for the PCDU was 4 patients per day which converts 
into  50% unused capacity. At the same time with the escalating patient census associated with 
the Kentucky Exchange insurance program, inpatient volume increased by 20%. Due to the 
influx of patients from the ED requiring inpatient beds, the unused beds in the PCDU were 
frequently assigned to other admission status.  Keeping in perspective, the PCDU was 
designed to admit pulmonary observation patients to the area. The influx of patients with 
different admission status and diagnosis types to the PCDU, was a primary factor that 
contributed to converting the PCDU beds back to medical-surgical beds.   
Another crucial factor that contributed to the conversion of the PCDU back to medical-
surgical beds was a lack of physician support. Physicians refused to admit patients to the 
PCDU due to personal preference and their lack of confidence with the PCDU staff’s ability to 
provide care. Resources allocated to staff the PCDU were much lower as compared to acute 
care or an inpatient bed. The staffing in the  PCDU was 1:5 nurse patient  ratio. Staffing in 
medical-surgical units in the same hospital  were 1:4 nurse patient ratio. A supportive 
leadership team and a systematic approach intended for the treatment of AECOPD are 
necessary in order for the PCDU to have remained open (Jagminas & Partridge, 2004) . Lack 
of physician support to admit patients to the PCDU is a major concern for future endeavors    
Limitations  
There were several limitations associated with this pilot.  The optimal metric for 
determining the success of observation units is by measuring readmission rates.  The literature 
supports observation units, not only to determine medical necessities, but also to reduce costs 
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associated with unplanned readmissions of patients with chronic disease (Ringquist, 2014). 
About $25 billion dollars each year is spent on 30-day hospital readmission for patients with 
chronic disease in United States (Robert Wood Johnson Foundation, 2013). Impacting 
readmission rates is a complex endeavor which requires healthcare organizations to create 
systems and structures to ensure that patients are able to manage their disease once they are 
discharged from the hospital. The operational definition for determining 30-day hospital 
readmissions defined by CMS does not include race, socioeconomics or noncompliance.  Further 
research is necessary to address healthcare equity, language barriers, health literacy, social 
determinates and noncompliance in order to provide patients with the tool and resources to help 
manage their disease (Billings et al., 2012). Therefore, this should be an area of critical 
importance for future studies that will share the results of multiple organizations and the 
utilization of observation units to lower readmission rates.   
The second limitation associated with the pilot is being able to control COPD 
observations of patients admitted to other nursing units within NAH. Although patients with 
AECOPD were admitted to the PCDU, the feasibility of replicating this strategy in another 
NHC facility is unknown.  
Because the study was a retrospective evaluation, the third limitation of the pilot was 
the functionality of the EMR predictive model. Unplanned hospital admissions in the current 
EMR are not identified according to patients with the diagnosis of COPD. In order to determine 
if the readmission was planned or unplanned, the physician must document the reason for 
readmission in the EMR. Risk factors built in the EMR are generalized to the entire patient 
population.  The current version of the EMR prediction model does not have the capability of 
27 
 
pulling data across multiple encounters. Therefore, the current readmission indicators within 
the model are very limited and without the evidence to support the validity of the model.  
Finally, there is no method for determining the severity of illness when patients are 
assigned to observation due to the fact that patients in observation status are billed using 
outpatient codes. Each code is assigned a dollar amount which translates to the cost of care.   
When calculating the cost of care, claims data according to outpatient codes are collected by 
payment and not by research. Methods for determining the cost of care are dependent on 
accurately coding the information documented in the chart for reimbursement.  
Recommendations 
Recommendations for bringing observation units into practice have many implications. 
The literature supports that using standardized practices can result in improved outcomes by 
reducing avoidable readmissions, and reducing direct variable cost (Decker et al., 2008). The 
intervention analyzed in the pilot used a standardized process and did show a reduction in direct 
variable cost. Prior to the implementation of the PCDU, there was no contingency plans to 
address the issues of potential low patient census in the unit. The business decision to pilot the 
PCDU was based on historical volumes of an average daily census of 7 patients per day who were 
in observation for COPD at Norton Audubon Hospital . Therefore, according to the 
data, the  assumptions were that the volumes would support the PCDU.  Additional studies with 
attention to developing stronger physician acceptance and process improvement holds 
opportunities.  Without the support from non-hospital employed Pulmonologists, the survival of 
the PCDU was a constant threat. Finally staffing was a major concern to physicians who sent their 
patients to the PCDU. Additional research is required in this area in order to ensure safe patient 
nurse ratios are in alignment with the evidence.  
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                NAH successfully developed a clinical decision unit specifically for cardiovascular 
disease.  Lessons learned from that experience were that the unit was closed, with admission 
only by a cardiologist, and there were well developed processes driven by protocols and order 
sets.  Consideration of establishing a unit with a narrowly defined focus on COPD appears to 
have potential benefits in reducing costs and outcomes.  The standardization of the process 
should involve the engagement of the physicians coordinating care, and would require a close 
relationship and communication among hospitalists and pulmonary specialists to develop the 
protocols and details of order sets to maximize return of adequate pulmonary function.  The 
process would have to be designed to rapidly identify patients that would benefit from acute 
inpatient treatment.  By having a standard approach, the training and focus of the nursing staff 
will improve the competencies of managing a complex set of patients. Coordinating care in this 
way encourages improved communication between physicians, nurses and patients, and 
subsequently reduce unnecessary and costly admissions.   
Conclusion 
The Affordable Care Act has transformed our nation’s healthcare system and 
reimbursement structure.  The shift in payment structures to improve quality, lower cost and to 
create a culture of sustainable outcomes has created urgency in today’s healthcare 
environment. Technology is an important aspect of care coordination across the continuum for 
patients with chronic disease.  In 2016, NHC is implementing an evidence-based predictive 
model in the EMR. Having a well-established electronic medical record with the capacity to 
drive analytics to determine contributing factors associated with hospital readmission is crucial 
in healthcare.  Strategies to reduce hospital re-admissions are targeting high-risk patients.   
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Reducing the number of patients who are readmitted to the hospital with COPD is a 
priority within NHC. Hospitals must make certain that systems and structures are in place to 
ensure that patients receive the right level of care at the right time and right place.  Diagnosis 
specific observation units are an innovative approach for providing an alternative level of care in 
which patients could benefit from an extended observation period.  Studies have shown that OUs 
reduce re-admission rates, control cost, reduce the LOS, and impact the utilization of ED visits 
(Suri, 2011).  Further research is recommended to identify other deliberate practices that can 










Appendix A. Capstone Charter 
Program Sponsor Jo Ellen Carpenter, DNP, 





Business Owner Amanda Newman   
Start/Target Date September 21, 2013 Project End Date: March 31, 2014 
Project Description  At the present time, patients typically placed under observation status are not placed in 
one geographic location.  These patients are mixed with inpatients, throughout the 
nursing units.  Due to this, the nursing staff is focused on inpatient care and may not be 
accustomed to the pace and urgency necessary to move observation patients quickly.  
The healthcare space is undergoing significant financial and clinical disruption.  
 
As a result of these changes, NHC must improve processes associated with the clinical 
management of patients with Chronic Disease.  The scope of this project is specific to 
patients admitted and discharged with a diagnosis of Chronic Obstructive Pulmonary 
Disease, COPD.  Cost per case for treating COPD is higher as compare to national 
benchmarks. COPD. COPD patients also have a high readmission rate.  This team will 
develop processes and tools to assist in cohorting patients,   keeping patients out of the 
hospital and streamline orders set by identifying best practice for managing patients with 
COPD.   
 
Project Scope  The project extends to patients that present in the Emergency Department and do not 
require patient admission but do not meet criteria to be discharged and can benefit from 
further observation.  Select direct admit patients that meet admission criteria may also be 
serviced in the Clinical Decision Unit. 
 
Goal (what will success look 
like?): 
 
 Transition the placement of patients typically placed as observation from being 
distributed throughout the hospital to a dedicated location.   
 Utilize criteria for admission and discharge of the patients served in the unit. 
 Prioritize the workload by focusing on targeted patient populations being managed 
through other clinical effectiveness initiatives creating the opportunity to maximize 
outcomes. 
 Maximize clinical outcomes by implementing evidence based protocols and order 
sets, reduce length of stay, visits to the Emergency Department patients and decrease 
readmission rates.  
 
Metric  Metric (Decrease in): 
1. Overall cost per case and other major cost drivers 
2. Overall LOS 
3. 31 day readmission rates (proper disease management function would focus and 
understand readmission failures) 
4. ED visits between admission 
 
Business Results  
 
 
In October 2012, the center of Medicare and Medicaid will financially penalty acute care 
facilities for patients readmitted within 30 days for any reason.  Norton Healthcare needs 
to develop processes that will decrease readmissions and decrease the cost of care per 
case yet maintain or improve the quality of that care.      
Benefit to Customers  Patients are cohorted to one area 
Patients do not return to the hospital. 






Appendix B: Chronic Obstructive Pulmonary Disease Report Demographics 
N= 692 Average Age Std deviation 
 65.45 11.83 
Gender No. Discharges Percentage 
Female 476 68.8% 
Male 216 31.2% 
Discharge disposition No. Discharges Percentage 
Home, self-care 536 77.5% 
Expired 3 0.4% 
Skilled Nursing Facility 61 8.8% 
Hospice 7 1.0% 
Home Health Services 73 10.5% 
Discharge/ transferred to rehab 
facility 
7 1.0% 
Against medical advice 5 0.7% 


















Appendix C.  Measure Phase, Chronic Obstructive Pulmonary Disease Report-(DRG, 190,191 
and 192) 
Measure Average Std 
deviation 
No. Discharges 
Direct variable Cost $ 2,966 $2,294 692 
Length of Stay 4.52 2.87 692 
    
 Rate No. 
Readmits 
No. Discharges 
Any ED 7 days readmission 3.1% 21 684 





















Appendix  D***Clinical Decision Unit Physician Orders for COPD and Asthma Exacerbation 
Admission 
NOTE: Check boxes below to initiate order 
Date:                                                                                                   Time: 
Place for observation 
Service Level: 
Admitting Physician: 
Anticipated length of stay: 
Anticipated post discharge needs: 
Bed request comment: 
Adult Code Status (Single Response) 
{}Full Code 
{}Allow a natural death (DNR) 
{}Adult DNR with comfort measure panel  
POC  
{}POCT blood glucose monitor                                           Routine, 4 times daily before     
meals                                                                                    a                                                                                                     
and at bedtime 
{}POCT blood glucose monitor                                           Routine, Once for 0 ,,,,                   
,                                                                                             occurrence  
{}POCT blood glucose monitor                                           Routine, every 6 hours 
 
Laboratory 
{}CBC w/Diff                                                                       Routine, Morning draw at 
0400 for 1 o   e                                                                                                                  o                                                                                                
occurrence 
{} Blood Gas , Arterial                                                        Routine, Once 
{}NT-ProBNP                                                                     Routine, Once 
{}Basic Metabolic Panel (BMP)                                         Routine, Morning draw at           
0                                                                                            0400 for 1 occurrence                                                                     
o                                                                                       
{}HCG, Qualitative                                                              STAT , once for 1                    
o                                                                                            occurrence, if not done in                
t                                                                                              the ED 
{}Comprehensive Metabolic Panel (CMP)                          STAT , once for 1                    
o                                                                                            occurrence, if not done in           
t                                                                                              to the ED       
Radiology 
{} XR Chest 2 VW                                                               Routine1 time imaging for 1 o              
.                                                                                            occurrence Reason for exam:                                                                                                               
e                                                                                            COPD/Asthma. 
I                                                                                                        Is patient pregnant? 
W                                                                                                     What is the patient’s sedation                                      





Appendix D (continues)***Clinical Decision Unit Physician Orders for COPD and Asthma 
Exacerbation Admission 
 
NOTE: Check boxes below to initiate order 
CT 
{} CT Chest wo contrast                                              Routine 1 time imaging for 1 reason for 
    o                                                                                for exam: COPD or Asthma 
0                                                                                                       Is patient pregnant? 
W                                                                                   What is the patient’s sedation                                      
r                                                                                      requirement?  
 
{} CT Chest wo & w contrast                                       Routine 1 time imaging for 1 reason for 
    o                                                                                 for exam: COPD or Asthma 
0                                                                                                       Is patient pregnant? 
W                                                                                   What is the patient’s sedation                                      





{}EKG 12 lead                                                  Routine, Once 
Q                                                                        Consult/Referring Cardiologist: 
A                                                                        Family Physician: 
R                                                                        Reason for exam: COPD/Asthma 
VTE Prophylaxis and Core Measure 
Mechanical Device, Medication and Contradictions 
All adult IP admission must be evaluated for VTE prophylaxis within 4 hours of admission. 
At least one of the following orders must be selected for these patients 
NOTE: If VTE screening score is greater than 1, please order mechanical compression device to 
comply with Core Measure requirements. 
 
{}Place mechanical compression device      Routine every 12 hours 
.                                                                     Mechanical Compression Device: Calf length 
{} Fondaparinux (Arixtra) injection              2.5 mg, Subcutaneous, every 24 hours                                    
.                                                                     Routine 
{} Enoxaparin (Lovenox) syringe                 40 mg, subcutaneous, every 24 hours                                           
.                                                                     Routine 
{}Low risk- no VTE prophylaxis needed 
{}INR greater than 3- no VTE prophylaxis needed 
{}Patient refused VTE prophylaxis 
{}Patient is possible risk for VTE but there is a contraindication to Mechanical and 
medication VTE prophylaxis - Admission 





Appendix  D (continues) ***Clinical Decision Unit Physician Orders for COPD and Asthma 
Exacerbation Admission 
NOTE: Check boxes below to initiate order 
Antibiotics 
{} Azithromycin (Zithromax) :  500mg oral, daily ,routine 
{} Doxycycline (Vibramycin) : 100mg, oral 2 times daily, routine 
 
Beta-2 Agonist 
{} Ipratropium-Albuterol Minineb& treatment and linked panel 
{} Albuterol-Ipratropium (Duo-neb) 0.5 – 2.5 mg/dl nebulizer    Nebulization, every.     .                                                                                                      
4 hours (RT)            
{} Nebulizer Treatment    routine , every 4 hours (RT)                 Routine                                                                                                       
{} Ipratropium-Albuterol Minineb & treatment  And Linked Panel 
{} Albuterol-Ipratropium (Duo-neb) 0.5 – 2.5 mg/dl nebulizer    Nebulization, every 2.          
..                                                                                                     hours (RT)                                                                                                          
e                                                                                                     Shortness of Air. Routine 
{} Nebulizer Treatment                                                                 Routine, every 2 hours.  .                                                                                                      
(RT) 
Corticosteroids ( Single Response) 
{} Methyl Prednisolone Sodium Succinate) Solumedrol             60 mg, Intravenous,                                                                                                      
Every 8 hours                     .                                                                                                      
Injection, Routine 
{}Methylprednisolone sodium succinate (Solumedrol)                40 mg, Intravenous                
,                                                                                                      Every 8 hours 
                                                                                                                   Injection, Routine 
{} Methyl Prednisolone Sodium Succinate )Solumedrol              20 mg, Intravenous,                   
,                                                                                                       Every 8 hours 
                 ,                                                                                                  Injection, Routine 
{} Methylprednisolone sodium succinate (Solumedrol)                 40 mg, oral, daily with    
.                                                                                                      breakfast 
Leukotriene Receptor Antagonists 
{}Montelukast (Singular) tablet                                                   10 mg, Oral, Nightly,          
,                                                                                                     Routine 
Stress Ulcer Prophylaxis (Single Response) 
{}Pantoprazole (Protonix) EC table                                              40 mg, Oral, Nightly,,       
,                                                                                                      Routine 
{} Famotidine (Pepcid) tablet                                                        20 mg, Oral,  2 times                        
,                                                                                                      daily , Routine 
Other 
{}Nicotine (Nicoderm C Q) 21 mg/24hr 1 patch, Transdermal, daily, starting                                                                                                                  
today at 9:00 AM 
















Readmission Score in Epic (RAM) RAM score appear in the patient header 
Classification (6-13)  Red/High Risk
                              (3 -5 ) Yellow/ Moderate Risk
                       (0-2 )  white/ Low Risk
All disciplines  are able to review contributing factors associated with the score
Nurse and Care Manager identifies 
contributing factors associated with the 
















Rapid Round: multidisciplinary: Rounding by exception 
(Readmission score, identification of risk factors allowing 


















Care coordination: Robust discharge planning, drivers of 
discharge disposition,  transitions  of care
Disposition
AVS to include discharge plan to mitigate re- 
hospitalization:










Appendix F. Medicare Diagnoses Related Group Reimbursement Benchmarks for COPD  
 
 
The National average payment for DRG is calculated by multiplying the current weight of the 
DRG by the national average hospital Medicare base rate.  The national average hospital 
Medicare rate is the average of the full up to date labor related and non-labor related amount 
published in the Federal Register, FY 2015, and Final Rule.  This information is provided as a 
benchmark reference only.  There is no official publication of the average hospital base rate: 
therefore, the national average payments provided in this table are approximated (Schmidt & 

































Appendix H: Program Study Timeline: A Pilot Study of a  Pulmonary Clinical Decision Unit on Outcomes in Patients with Chronic 
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